Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer
Clinical trial NCT00189579 · TERMINATED
Trial details
- NCT number
- NCT00189579
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.